Results 21 to 30 of about 97,239 (277)

A Worldwide Perspective of Atypical Pathogens in Community-Acquired Pneumonia [PDF]

open access: yes, 2007
Rationale: Controversy still exists in the international literature regarding the need to use antimicrobials covering atypical pathogens when initially treating hospitalized patients with community-acquired pneumonia (CAP).
T. J. Marrie   +14 more
core   +1 more source

Clinical Comparative Study of Sulbactam/Ampicillin and Imipenem/Cilastatin in Elderly Patients with Community-Acquired Pneumonia [PDF]

open access: yes, 2006
Objective: To evaluate the clinical usefulness of sulbactam/ampicillin therapy for community-acquired pneumonia in the elderly. Methodology: A randomized prospective clinical study was conducted in the elderly patients with moderate-to-severe community ...
Higashiyama, Yasuhito   +10 more
core   +1 more source

Chlamydia species as a cause of community-acquired pneumonia in Canada. [PDF]

open access: yes, 2003
Chlamydia pneumoniae has been implicated as a cause of community-acquired pneumonia (CAP) in several studies. However, there has been no comprehensive study of the role of Chlamydia species (C. pneumoniae, C.
De Carolis, E   +4 more
core   +1 more source

Adjuvant Inhaled Corticosteroids in Community-Acquired Pneumonia: A Review Article

open access: yesMedical Sciences, 2021
Community-acquired pneumonia is still a major cause of morbidity and mortality worldwide. Since the inflammatory response induced by the immune system is often a major contributor to the lung injury, it becomes reasonable to assess the potential benefit ...
Faeq R. Kukhon, Emir Festic
doaj   +1 more source

Legionnaires' Disease - Results of a Multicenter Canadian Study

open access: yesCanadian Journal of Infectious Diseases, 2003
BACKGROUND: There has never been a cross-Canada surveillance project to determine the rate of Legionella species as a cause of community-acquired pneumonia requiring hospitalization and to determine whether there are any regional differences in the rates
Thomas J Marrie   +4 more
doaj   +1 more source

ETIOLOGICAL FEATURES AND ANTIMICROBIAL RESISTANCE IN HEALTHCARE-ASSOCIATED PNEUMONIA

open access: yesArta Medica, 2020
Objectives. Healthcare-associated pneumonia develops in patients undergoing regular medical procedures or has a longterm contact with the hospital environment. Several studies have shown important differences in healthcare-associated pneumonia, comparing
Cristina Toma   +2 more
doaj   +1 more source

A Clinical Comparative Study of Piperacillin and Sulbactam/Ampicillin in Patients with Community-Acquired Bacterial Pneumonia [PDF]

open access: yes, 2009
Objective To evaluate the clinical usefulness of piperacillin (4 g/day) therapy for community-acquired pneumonia compared to sulbactam/ampicillin (6 g/day).
Higashiyama, Yasuhito   +10 more
core   +1 more source

Community-acquired Acinetobacter baumannii pneumonia: a rare case in Brazil [PDF]

open access: yes, 2022
Acinetobacter baumannii, a common pathogen in nosocomial infections, is a rare cause of community-acquired pneumonia. This report highlights the difficulties in its early diagnosis and effective treatment, as it is a multidrug-resistant microorganism ...
Rodrigo Juliano Molina (7475981)   +2 more
core   +1 more source

Biomarkers of host response predict primary end-point radiological pneumonia in Tanzanian children with clinical pneumonia : a prospective cohort study [PDF]

open access: yes, 2015
Diagnosing pediatric pneumonia is challenging in low-resource settings. The World Health Organization (WHO) has defined primary end-point radiological pneumonia for use in epidemiological and vaccine studies.
Nimerta Rajwans   +43 more
core   +1 more source

Community acquired pneumonia [PDF]

open access: yesArchives of Disease in Childhood, 2001
We live in an era when medical practice is increasingly regulated by guidelines and protocols. Ideally, such guidance should be evidence based, and in particular it is generally recommended that advice on medical treatment should be based on the results of adequately powered, double blind, placebo controlled trials or, some would say, better still, a ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy